Amarin Drug Approval Could Come Today; Shares Rising
July 26, 2012 at 11:16 AM EDT
Amarin’s (AMRN) cholesterol drug AMR101 is likely to be approved by the FDA today, writes Cannacord Genuity analyst Ritu Baral in a note. The FDA’s reviuew period expires today, and analysts have been predicting that the drug will be approved. Baral also expects that the ruling could give AMR101 patent-protection for five years. JP Morgan [...]
